Literature DB >> 18686046

Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

P S Vosler1, C S Brennan, J Chen.   

Abstract

Calpain is a ubiquitous calcium-sensitive protease that is essential for normal physiologic neuronal function. However, alterations in calcium homeostasis lead to persistent, pathologic activation of calpain in a number of neurodegenerative diseases. Pathologic activation of calpain results in the cleavage of a number of neuronal substrates that negatively affect neuronal structure and function, leading to inhibition of essential neuronal survival mechanisms. In this review, we examine the mechanistic underpinnings of calcium dysregulation resulting in calpain activation in the acute neurodegenerative diseases such as cerebral ischemia and in the chronic neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, prion-related encephalopathy, and amylotrophic lateral sclerosis. The premise of this paper is that analysis of the signaling and transcriptional consequences of calpain-mediated cleavage of its various substrates for any neurodegenerative disease can be extrapolated to all of the neurodegenerative diseases vulnerable to calcium dysregulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18686046      PMCID: PMC2726710          DOI: 10.1007/s12035-008-8036-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  304 in total

1.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

2.  Protection of mature oligodendrocytes by inhibitors of caspases and calpains.

Authors:  Joyce A Benjamins; Liljana Nedelkoska; Edwin B George
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

4.  Neutral protease in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases.

Authors:  T Inuzuka; S Sato; H Baba; T Miyatake
Journal:  Acta Neurol Scand       Date:  1987-07       Impact factor: 3.209

5.  Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain.

Authors:  Zhihou Liang; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2007-10-01       Impact factor: 5.372

6.  Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice.

Authors:  L Siklós; J I Engelhardt; M E Alexianu; M E Gurney; T Siddique; S H Appel
Journal:  J Neuropathol Exp Neurol       Date:  1998-06       Impact factor: 3.685

7.  Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'.

Authors:  T Yamashima; Y Kohda; K Tsuchiya; T Ueno; J Yamashita; T Yoshioka; E Kominami
Journal:  Eur J Neurosci       Date:  1998-05       Impact factor: 3.386

8.  Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets.

Authors:  Q X Li; G Evin; D H Small; G Multhaup; K Beyreuther; C L Masters
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

9.  Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis.

Authors:  T Nakagawa; J Yuan
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

Review 10.  Glycogen synthase kinase 3: a key regulator of cellular fate.

Authors:  J E Forde; T C Dale
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

View more
  151 in total

Review 1.  Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?

Authors:  Julia S Gelman; Lloyd D Fricker
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

2.  Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides.

Authors:  Lloyd D Fricker; Julia S Gelman; Leandro M Castro; Fabio C Gozzo; Emer S Ferro
Journal:  J Proteome Res       Date:  2012-02-16       Impact factor: 4.466

3.  Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2).

Authors:  Joel M Brittain; Liang Chen; Sarah M Wilson; Tatiana Brustovetsky; Xiang Gao; Nicole M Ashpole; Andrei I Molosh; Haitao You; Andy Hudmon; Anantha Shekhar; Fletcher A White; Gerald W Zamponi; Nickolay Brustovetsky; Jinhui Chen; Rajesh Khanna
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

Review 4.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 5.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

6.  Ischemia-induced calpain activation causes eukaryotic (translation) initiation factor 4G1 (eIF4GI) degradation, protein synthesis inhibition, and neuronal death.

Authors:  Peter S Vosler; Yanqin Gao; Christopher S Brennan; Akiko Yanagiya; Yu Gan; Guodong Cao; Feng Zhang; Simon J Morley; Nahum Sonenberg; Michael V L Bennett; Jun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 7.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

8.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

9.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

Review 10.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.